On Oct. 10, life sciences regulatory & compliance partner Katherine Wang (Shanghai) presented to the European Union Chamber of Commerce pharmaceutical working group on highlights of China’s new drug administration law and examined the impact on companies’ China market access strategies and unresolved issues.
Nearly 20 legal professionals from leading biopharmaceutical companies attended the event.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.